Monograph based upon Proceedings of the International Symposium held in Interlaken, Switzerland, September 2-5, 1980
First Statement of Responsibility
edited by Forrester Cockburn, Richard Gitzelmann.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Dordrecht
Name of Publisher, Distributor, etc.
Springer Netherlands
Date of Publication, Distribution, etc.
1982
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
(296 pages)
CONTENTS NOTE
Text of Note
Section One Pathogenic Mechanisms of Inborn Errors: Clinical Implications of Biochemical Diversity --; 1 Molecular aspects of genetic heterogeneity --; 2 Inborn errors of purine metabolism-The Milner Lecture --; 3 Vitamin-responsive inherited metabolic disorders: propionic acidaemia and methylmalonic acidaemia --; 4 Homocystinuria: clinical and biochemical heterogeneity --; 5 Hereditary defects of steroid biosynthesis --; 6 Blood-brain barrier amino-acid transport: clinical implications --; Section Two Treatment: New Aspects and Limits, Transplantation, Replacement Therapy, Genetic Engineering --; 7 Recent studies on the maturation of lysosomal enzymes --; 8 Enzyme substitution by fibroblast transplantation --; 9 Artificial cell-encapsulated enzymes and adsorbents in congenital metabolic disorders --; 10 Prospects for enzyme replacement therapy in heritable metabolic disorders --; Section Three Inborn Errors of Metabolism affecting Brain Development (Animal Models) --; 11 Inborn errors of metabolism affecting brain development-Introduction --; 12 Mutations in mice affecting brain development and their correlations with human diseases --; 13 Murine mutations affecting myelination: models to study myelin diseases in the human --; 14 The effect of phenylalanine on myelin metabolism in adolescent rats --; 15 Abnormal oligodendrocyte differentiation in a mouse mutant with defect in myelination --; Section Four Consequences of Inborn Errors of Metabolism for the Individual, the Family and Society --; 16 Inborn errors of metabolism consequences of long-term treatment for the individual, as derived from observations in phenylketonuria --; 17 Social aspects of the handicapped person --; 18 Psychological and educational aspects of handicap --; 19 Repercussions of screening --; 20 Some principles in the management of inherited metabolic disease.